The growing global prevalence of type 2 diabetes and obesity has significantly increased demand for GLP-1 receptor agonists such as semaglutide, liraglutide, and tirzepatide, which are known for their ability to manage blood glucose levels, support weight loss, and improve cardiovascular outcomes
While these GLP-1 meds offer remarkable benefits for weight loss and metabolic health, theyre creating unexpected challenges for digestive healththe side effects are no joke
Niacin is an important B vitamin that helps raise levels of high-density lipoproteins (HDL), the good cholesterol, and lower triglycerides in the body and bloodstream
Metabolic profiling, loss-of-function approaches, and pharmacologic activation studies demonstrated that NRF2 is both necessary and sufficient to restrain ILC2 effector function
Support from family, friends, or a community group can make a big difference
Impact of Nox5 polymorphisms on basal and stimulus-dependent ROS generation